Capital Asset Advisory Services’s Tiziana Life Sciences TLSA Stock Holding History

Capital Asset Advisory Services’s Portfolio TLSA Stock Details TLSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-37,834	Closed	-$55K	–	708
2021 Q3	$55K	Hold	37,834	–	–	0.01%	503
2021 Q2	$89K	Hold	37,834	–	–	0.01%	495
2021 Q1	$105K	Hold	37,834	–	–	0.02%	459
2020 Q4	$76K	Sell	37,834 -2,618	-6%	-$8.28K	0.01%	524
2020 Q3	$135K	Sell	40,452 -60,638	-60%	-$236K	0.03%	326
2020 Q2	$186K	Buy	101,090 +60,654	+150%	+$111K	0.04%	328
2020 Q1	$72K	Buy	+40,436	New	+$38.7K	0.02%	343

Other funds holding TLSA

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AFP

Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Capital Asset Advisory Services's TLSA Position: Q4 2021 in Review

Capital Asset Advisory Services sold out of Tiziana Life Sciences (TLSA) in Q4 2021, closing a stake of 37,834 shares — an estimated $55K sold.

Capital Asset Advisory Services first reported a position in TLSA in Q1 2020 and held it in 7 quarters. The position peaked at $186K in Q2 2020. 23 funds tracked by Wall St. Rank hold TLSA as of Q4 2021.

Capital Asset Advisory Services reported no remaining Tiziana Life Sciences position as of Q4 2021 after selling out during the quarter.
Capital Asset Advisory Services sold 37,834 Tiziana Life Sciences shares in Q4 2021, an estimated $55K.
Capital Asset Advisory Services first reported a position in Tiziana Life Sciences in Q1 2020 and held it in 7 quarters.
Capital Asset Advisory Services's Tiziana Life Sciences position peaked at $186K in Q2 2020.
23 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q4 2021.

Based on Capital Asset Advisory Services's 13F filing for Q4 2021, filed 4 Feb 2022.